A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Phase 3
- Conditions
- Uremic Pruritus
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2010-02-04
- Lead Sponsor
- Acologix, Inc.
- Target Recruit Count
- 350
- Registration Number
- NCT00793156
An Observational Study of Pruritus Amongst Hemodialysis Patients
- Conditions
- PruritusKidney Failure, ChronicHemodialysisChronic Disease
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2008-07-15
- Lead Sponsor
- Acologix, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00715260
- Locations
- 🇺🇸
Kidney Care Associates, Augusta, Georgia, United States
🇺🇸FMC Metaire, Metaire, Louisiana, United States
🇺🇸Western New England Renal Associates, Springfield, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath